Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5824)
All Articles published online
|
Publishing Process of This Article
|
Nov 27, 2018 (publication date) through Jan 31, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Sobotka LA, Hinton A, Conteh LF. African Americans are less likely to receive curative treatment for hepatocellular carcinoma. World J Hepatol 2018; 10(11): 849-855 [PMID: 30533185 DOI: 10.4254/wjh.v10.i11.849] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i11/849.htm |
| Number | Citing Articles |
| 1 |
N. Begum Ozturk, Hoang Nhat Pham, Rama Mouhaffel, Ramzi Ibrahim, Marwan Alsaqa, Ahmet Gurakar, Behnam Saberi. A Longitudinal Analysis of Mortality Related to Chronic Viral Hepatitis and Hepatocellular Carcinoma in the United States. Viruses 2024; 16(5): 694 doi: 10.3390/v16050694
|
| 2 |
Emeka P. Agudile, Eduardo A. Vega, Oscar Salirrosas, Ukamaka M. Agudile, Ariana M. Chirban, Christopher Lathan, George P. Sorescu, Bruno C. Odisio, Elena Panettieri, Claudius Conrad. Temporal trends of health disparity in the utilization of curative-intent treatments for hepatocellular carcinoma: are we making progress?. Journal of Gastrointestinal Surgery 2024; 28(9): 1392 doi: 10.1016/j.gassur.2024.05.015
|
| 3 |
Faith Ajayi, Jenny Jan, Amit G. Singal, Nicole E. Rich. Racial and Sex Disparities in Hepatocellular Carcinoma in the USA. Current Hepatology Reports 2020; 19(4): 462 doi: 10.1007/s11901-020-00554-6
|
| 4 |
Mitchell L Ramsey, Michael R Wellner, Kyle Porter, Stephen E Kirkby, Susan S Li, Luis F Lara, Sean G Kelly, A James Hanje, Lindsay A Sobotka. Cystic fibrosis patients on cystic fibrosis transmembrane conductance regulator modulators have a reduced incidence of cirrhosis. World Journal of Hepatology 2022; 14(2): 411-419 doi: 10.4254/wjh.v14.i2.411
|
| 5 |
Nicole E. Rich, Christian Carr, Adam C. Yopp, Jorge A. Marrero, Amit G. Singal. Racial and Ethnic Disparities in Survival Among Patients With Hepatocellular Carcinoma in the United States: A Systematic Review and Meta-Analysis. Clinical Gastroenterology and Hepatology 2022; 20(2): e267 doi: 10.1016/j.cgh.2020.12.029
|
| 6 |
Jacquelyn Carr, Da Eun Cha, Tali Shaltiel, Serena Zheng, Cleo Siderides, Benjamin Golas, Daniel Labow, Deepa Magge, Noah Cohen, Andrea Branch, Umut Sarpel. African Immigrants in New York City with Hepatitis B-Related Hepatocellular Carcinoma Demonstrate High Morbidity and Mortality. Journal of Immigrant and Minority Health 2022; 24(2): 327 doi: 10.1007/s10903-021-01205-8
|
| 7 |
Wei Yu, Sanjit K. Roy, Yiming Ma, Thomas A. LaVeist, Sharmila Shankar, Rakesh K. Srivastava. Higher expression of SATB2 in hepatocellular carcinoma of African Americans determines more aggressive phenotypes than those of Caucasian Americans. Journal of Cellular and Molecular Medicine 2019; 23(12): 7999 doi: 10.1111/jcmm.14652
|
| 8 |
Connor Griffin, Uchenna Agbim, Azaan Ramani, Nagasri Shankar, Fasiha Kanwal, Sumeet K. Asrani. Underestimation of Cirrhosis-Related Mortality in the Medicare Eligible Population, 1999–2018. Clinical Gastroenterology and Hepatology 2023; 21(1): 223 doi: 10.1016/j.cgh.2021.10.036
|
| 9 |
Kavin Sugumar, Sarah C. Markt, Jonathan J. Hue, Richard S. Hoehn, Richard T. Lee, Kenneth D. Chavin, Luke D. Rothermel, Jordan M. Winter, Jeffrey M. Hardacre, John B. Ammori, Lee M. Ocuin. Black race is independently associated with underutilization of transplantation for clinical T1 hepatocellular carcinoma. HPB 2022; 24(6): 925 doi: 10.1016/j.hpb.2021.10.023
|
| 10 |
Daniela Goyes, John Paul Nsubuga, Esli Medina-Morales, Romelia Barba, Vilas Patwardhan, Behnam Saberi, Zachary Fricker, Alan Bonder. Race/Ethnicity Is Not Independently Associated with Risk of Adverse Waitlist Removal among Patients with HCC Exception Points. Journal of Clinical Medicine 2021; 10(24): 5826 doi: 10.3390/jcm10245826
|
| 11 |
Vivek Chavda, Kelsee K. Zajac, Jenna Lynn Gunn, Pankti Balar, Avinash Khadela, Dixa Vaghela, Shruti Soni, Charles R. Ashby, Amit K. Tiwari. Ethnic differences in hepatocellular carcinoma prevalence and therapeutic outcomes. Cancer Reports 2023; 6(S1) doi: 10.1002/cnr2.1821
|
| 12 |
Premal S. Trivedi, Bernardo Guerra, Vishal Kumar, Goke Akinwande, Derek West, Nadine Abi-Jaoudeh, Gloria Salazar, Paul Rochon. Healthcare Disparities in Interventional Radiology. Journal of Vascular and Interventional Radiology 2022; 33(12): 1459 doi: 10.1016/j.jvir.2022.08.026
|
| 13 |
Fernand Bteich, Kush Desai, Chenxin Zhang, Anahat Kaur, Rachel Levy, Lydia Bioh, Aaron Wang, Sharmin Sultana, Andreas Kaubisch, Milan Kinkhabwala, Sarah Bellemare, Shabnam Fidvi, Devaraju Kanmaniraja, Robert Berkenblit, Jee-Young Moon, Adebola Adedimeji, Clara Tow, Yvonne Saenger. Immunotherapy Efficacy in Advanced Hepatocellular Carcinoma in a Diverse and Underserved Population in the United States. Journal of Hepatocellular Carcinoma 2024; : 257 doi: 10.2147/JHC.S436804
|
| 14 |
Liat Gutin, Francis Yao, Jennifer L. Dodge, Joshua Grab, Neil Mehta. Comparison of Liver Transplant Wait-List Outcomes Among Patients With Hepatocellular Carcinoma With Public vs Private Medical Insurance. JAMA Network Open 2019; 2(8): e1910326 doi: 10.1001/jamanetworkopen.2019.10326
|
| 15 |
Sedra Tibi, Vivian Tieu, Suat Babayigit, Jun Ling. Influence of Health Insurance Types on Clinical Cancer Care Accessibility and Quality Using All of Us Database. Medicina 2024; 60(4): 623 doi: 10.3390/medicina60040623
|